/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Vocera to Present at Upcoming Conferences
SAN JOSE, Calif.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/search?q=%24VCRA&src=ctag” target=”_blank”gt;$VCRAlt;/agt;–Vocera
Communications, Inc. (NYSE:VCRA), a recognized leader in clinical
communication and workflow solutions, today announced that its senior
executives will be participating in several upcoming conferences.
Justin Spencer, Chief Financial Officer of Vocera, will be presenting at
the Bank of America Merrill Lynch Healthcare Conference on Wednesday,
May 15 at 10:40 a.m. PT in Las Vegas. On Wednesday, May 29, he will be
conducting one-on-one meetings with investors at the Craig Hallum
Institutional Investors’ Conference in Minneapolis.
Brent Lang, President and CEO of Vocera, will be presenting on Tuesday,
June 4 at the Jefferies 2019 Global Healthcare Conference in New York.
Please check investors.vocera.com
for the specific time. Lang will also be presenting on Wednesday, June 5
at 12:40 p.m. CT at the 39th Annual William Blair Growth
Stock Conference in Chicago.
The presentations will be available as a webcast, both live and
archived, through the Vocera website at investors.vocera.com.
The replay will be available for 90 days following the live broadcast.
Important Notice Regarding Forward-Looking Statements
Comments or responses to questions at the conference may contain
forward-looking information, including statements regarding projected
operating results and anticipated market opportunities for Vocera. This
forward-looking information is subject to risks and uncertainties
described in Vocera’s filings with the Securities and Exchange
Commission, and actual results or events may differ materially.
About Vocera
The mission of Vocera Communications, Inc. is to simplify and improve
the lives of healthcare professionals and patients, while enabling
hospitals to enhance quality of care and operational efficiency. In
2000, when the company was founded, we began to forever change the way
care teams communicate. Today, Vocera offers the leading platform for
improving clinical communication and workflow. More than 1,850
facilities worldwide, including nearly 1,600 hospitals and healthcare
facilities, have selected our clinical communication and workflow
solutions. Care team members use our solutions to communicate and
collaborate with co-workers by securely texting or calling, and to be
notified of important alerts and alarms. They can choose the right
device for their role or task, including smartphones or our hands-free,
wearable Vocera Smartbadge and Vocera Badge. Interoperability between
the Vocera Platform and more than 140 clinical and operational systems
helps reduce alarm fatigue; speed up staff response times; and improve
patient care, safety, and experience. In addition to healthcare, Vocera
is at home in luxury hotels, aged care facilities, nuclear power
facilities, schools, libraries, retail stores, and more. Vocera
solutions make a difference in any industry where workers are on the
move and need to connect instantly with team members and access
resources or information quickly. In 2017, Vocera made the list of
Forbes 100 Most Trustworthy Companies in America. Learn more at http://www.vocera.com
and follow @VoceraComm on Twitter.
Vocera® and the Vocera logo are trademarks of Vocera Communications,
Inc. registered in the United States and other jurisdictions. All other
trademarks appearing in this release are the property of their
respective owners.
Contacts
Investors and Analysts:
Sue Dooley
Vocera Communications
408.882.5971
[email protected]
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Cannabis
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
Humboldt
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
Apollo Green to distribute Humboldt Seed Company clonal cannabis genetics to Germany, Portugal and Australia
SAN FRANCISCO, April 30, 2024 /PRNewswire/ — Humboldt Seed Company (HSC), California’s leading cannabis seed producer, has announced a partnership with Canadian-based Apollo Green to make eight breeder cuts available to researchers, licensed commercial cultivators and home growers in legal markets worldwide. This first-to-market clonal genetics release is a significant milestone and will expand access to distinctive, high-quality cannabis genetics in both established and emerging global markets including Germany, Portugal and Australia.
The curated, breeder-verified selection includes pioneering triploid genetics, such as OG Triploid and Donutz Triploid alongside the legendary cult classic Blueberry Muffin. Also available are All Gas OG with a THC content of 21% and four high-THC strains in the 30-35% range: Golden Sands, Guzzlerz, Jelly Donutz and Orange Creampop. These selections represent the top .01% from HSC’s extensive California pheno-hunting program.
Exports will begin in May under Apollo Green’s Canadian federal cannabis license. All shipments have Canadian phytosanitary certification, ensuring plants have been inspected, and are clean and free of pests.
“Access for all to quality genetics has been our core focus since the beginning,” said HSC Co-founder and Chief Science Officer, Benjamin Lind. “Our science-based approach to breeding aligns perfectly with Apollo Green’s high standards and we are excited to be able to extend these hand-selected cuts to a wider audience, especially at this pivotal time where we’re seeing positive regulatory changes globally.”
Oisin Tierney, Apollo Green Director of Business Development, said, “California has long been recognized for setting industry standards, and we are proud to play a role in bringing these esteemed genetics to cultivators worldwide. The triploids are especially noteworthy in terms of the unprecedented potential for enhanced plant vigor, higher yields, shorter flowering times and superior returns for solventless extraction.”
About Humboldt Seed Company
Established in 2001, Humboldt Seed Company is a Northern California heritage brand providing quality cannabis genetics to commercial cultivators and home growers in legalized states across the U.S. and international markets including Spain, Canada, Jamaica, South Africa, Colombia, France, Portugal, Greece, the UK, Malta and Thailand. With a focus on environmental and social justice, they combine traditional breeding and modern scientific practices in their strain development program. They have served the cannabis community for over two decades.
For more information visit https://humboldtseedcompany.com/.
About Apollo Green
Licensed since 2019, Apollo Green is Canada’s leader in cannabis genetics. The company’s mission is to provide an ever-growing bank of seeds and clones to medical patients and recreational consumers. Apollo Green provides clean, trusted cannabis seeds and clones, which are backed by the foremost tissue culture technology to reduce risks, costs and time-to-market for licensed producers around the world. Apollo Green is passionate about cannabis genetics.
For more information visit https://apollogreen.com/.
Media contact
Jaana Prall
[email protected]
Logo – https://mma.prnewswire.com/media/2328955/Humboldt_Seed_Company_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/humboldt-seed-company-partners-with-apollo-green-to-bring-california-cannabis-genetics-to-the-global-marketplace-302131618.html
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Innocan2 weeks ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf2 weeks ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis2 weeks ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
Cannabis6 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
SCHWAZZE6 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Humboldt6 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
Cannabis6 days ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis4 days ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III